Related Experiment Video
Updated: Jul 8, 2026

Applying Stereotactic Injection Technique to Study Genetic Effects on Animal Behaviors
Published on: May 10, 2015
Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent
Rajkumar Ramamoorthy1, Mahesh Radhakrishnan, Minasri Borah
1Pharmacy Group, Birla Institute of Technology & Science, Faculty Division - III, Pilani, Rajasthan, India. rajkumarrna@yahoo.com
Abstract:
The present behavioural investigation evaluates the antidepressant potential of ondansetron (OND), a widely used (in management of cancer chemotherapy-induced nausea and emesis) 5-HT3 receptor antagonist. Separate groups of mice received acute or chronic treatment of OND (0.005-1000 microg/kg), and were subjected to spontaneous locomotor activity test or antidepressant assays, namely, the forced swim and tail suspension tests. Interaction studies with fluoxetine, venlafaxine, desipramine and 8-hydroxy-2-(di-n-propylamino) tetralin were conducted in the forced swim test. The effect of OND (0.01-1000 microg/kg) in combination with paroxetine (10 mg/kg, for 14 days) on the behaviour of male bulbectomized or sham-operated rats was also assessed. The postbulbectomy behavioural analysis included exploration in the open field and elevated plus maze. OND exhibited a biphasic dose-response profile, with antidepressant-like effects peaking at 0.1 microg/kg, in the forced swim and tail suspension tests. None of the tested doses influenced spontaneous locomotor activity. Chronic OND pretreatment augmented the antidepressant effects of fluoxetine and venlafaxine but did not influence the effects of desipramine or 8-hydroxy-2-(di-n-propylamino) tetralin. Chronic OND (10 microg/kg) reversed hyperactivity in the open field, and decreased the percentage entry and time spent in open arms in the elevated plus maze. Summing up, it is observed that OND exhibits antidepressant-like effects, possibly mediated through postsynaptic 5-HT3 receptors.
Insights
Ondansetron (OND), a 5-HT3 receptor antagonist, demonstrates antidepressant-like effects in behavioral tests. Chronic OND enhances other antidepressants and modulates anxiety-related behaviors, suggesting therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Ondansetron (OND) is a 5-HT3 receptor antagonist primarily used for chemotherapy-induced nausea and emesis.
- The role of 5-HT3 receptors in mood regulation and potential antidepressant effects of OND is not fully understood.
Purpose of the Study:
- To investigate the antidepressant potential of ondansetron (OND) using established behavioral models in rodents.
- To explore the interaction of OND with other antidepressant medications and its effects on anxiety-related behaviors.
Main Methods:
- Acute and chronic treatments of OND were administered to mice and rats.
- Behavioral assays included spontaneous locomotor activity, forced swim test, tail suspension test, open field test, and elevated plus maze.
- Drug interaction studies were performed with fluoxetine, venlafaxine, desipramine, 8-hydroxy-2-(di-n-propylamino) tetralin, and paroxetine.
Main Results:
- OND exhibited a biphasic, dose-dependent antidepressant-like effect, peaking at 0.1 microg/kg in forced swim and tail suspension tests.
- Chronic OND pretreatment potentiated the antidepressant effects of fluoxetine and venlafaxine.
- OND administration reversed hyperactivity and reduced anxiety-like behaviors in bulbectomized rats.
Conclusions:
- Ondansetron displays antidepressant-like properties, potentially mediated via postsynaptic 5-HT3 receptors.
- OND may enhance the efficacy of certain existing antidepressant drugs.
- The findings suggest OND as a potential therapeutic agent for depression and anxiety disorders.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antipsychotic Drugs: Typical and Atypical Agents
